septemb
novemb
conduct
serosurvey
boend
health
zone
locat
km
northwest
kinshasa
capit
drc
provinc
tshuapa
figur
individu
met
elig
criteria
year
old
healthi
fever
ill
report
time
enrol
work
health
facil
report
activ
involv
boend
outbreak
respons
approach
enrol
studi
particip
screen
sign
current
ill
fever
particip
includ
current
analysi
report
ever
suspect
infect
ebov
total
hcw
consent
enrol
studi
health
facil
hospit
health
center
health
post
church
provid
health
servic
commun
studi
includ
sociodemograph
epidemiolog
questionnair
sampl
collect
blood
specimen
frozen
store
test
obtain
consent
particip
venipunctur
redtop
vacutain
tube
bd
bioscienc
process
aliquot
serum
frozen
store
institut
nation
de
recherch
biomedical
kinshasa
ship
blood
system
research
institut
san
francisco
california
perform
remain
serolog
neutral
assay
classif
base
world
health
organ
system
classif
formal
hcw
defin
individu
work
health
servic
includ
clinic
staff
physician
nurs
laboratori
staff
administr
worker
hospit
health
center
includ
cleaner
driver
secur
commun
health
worker
inform
hcw
defin
tradit
healer
pastor
nontradit
individu
provid
care
hcw
classifi
potenti
exposur
patient
base
report
occup
direct
contact
defin
hcw
direct
contact
sick
patient
includ
doctor
nurs
tradit
healer
indirect
contact
defin
hcw
direct
contact
sick
patient
contact
biolog
specimen
patient
materi
famili
member
sick
patient
eg
laboratori
technician
room
cleaner
unlik
contact
defin
hcw
unlik
contact
sick
patient
includ
posit
hospit
guard
administr
classif
relat
patient
care
tabl
human
antiebov
gp
igg
antiebov
np
igg
titer
measur
use
commerci
avail
enzymelink
immunosorb
assay
elisa
kit
alpha
diagnost
intern
follow
manufactur
protocol
methodolog
describ
elsewher
base
manufactur
calibr
sampl
classifi
mildli
reactiv
serum
antibodi
concentr
unitsml
control
calibr
reactiv
titer
unitsml
analysi
includ
consid
reactiv
unitsml
ctermin
domain
ebov
base
pair
clone
plasmid
transfect
cell
gener
renilla
luciferas
antigen
fusion
protein
cell
lysat
harvest
use
immunoprecipit
assay
protein
agaros
bead
test
serum
dilut
describ
burbelo
et
al
test
procedur
describ
elsewher
reactiv
determin
rel
luciferas
signal
postimmunoprecipit
least
standard
deviat
greater
background
signal
determin
mean
previous
identifi
sampl
ebov
human
immunodefici
viru
pseudotyp
virus
gener
describ
previous
pseudotyp
viru
neutral
assay
perform
infect
rate
presenc
human
serum
sampl
express
percentag
infect
presenc
neg
control
serum
consid
neutral
serum
patient
least
neutral
approxim
viru
dilut
compar
appropri
control
result
multipl
assay
compar
explor
overlap
ebov
seroreact
ran
crosstabul
sociodemograph
factor
report
occup
explor
descript
characterist
popul
compar
factor
seropreval
assay
assess
differ
factor
use
fisher
exact
test
sensit
analys
conduct
includ
mildli
reactiv
antibodi
titer
reactiv
antibodi
titer
analys
complet
use
r
sa
version
sa
institut
softwar
ethic
approv
obtain
institut
review
board
univers
california
lo
angel
field
school
public
health
kinshasa
school
public
health
drc
among
hcw
male
femal
tabl
median
age
hcw
year
interquartil
rang
year
half
particip
work
health
facil
includ
gener
hospit
health
center
health
post
report
work
facil
wherea
particip
identifi
work
facil
includ
tradit
healer
pastor
commun
worker
approxim
half
direct
contact
patient
wherea
indirect
contact
unlik
patient
contact
overal
hcw
gp
reactiv
np
reactiv
reactiv
demonstr
neutral
male
higher
seropreval
compar
femal
regardless
test
vs
respect
p
show
signific
differ
gp
reactiv
vs
respect
p
np
reactiv
vs
respect
p
age
statist
signific
seroreact
assay
decreas
increas
age
among
hcw
seroreact
least
assay
figur
greatest
overlap
respons
across
hcw
np
gp
seroposit
n
importantli
neutralizationposit
individu
also
reactiv
least
distinct
viral
protein
ie
either
andor
np
demonstr
neutral
capac
n
present
np
reactiv
howev
hcw
seroreact
assay
statist
signific
differ
serolog
respons
observ
across
direct
indirect
unlik
patient
contact
occup
categori
consider
heterogen
serolog
respons
across
occup
type
tabl
figur
scatterplot
present
figur
present
distribut
test
result
hcw
contact
type
among
hcw
consid
direct
contact
patient
tradit
healer
pastor
midwiv
highest
gp
np
seropreval
exclud
physician
due
sampl
size
n
wherea
red
cross
worker
highest
seropreval
neutral
capac
respect
p
hcw
indirect
contact
patient
demonstr
similar
heterogen
across
occup
classifi
unlik
contact
patient
highest
gp
seropreval
among
group
health
administr
guard
respect
use
multiassay
approach
data
suggest
least
serolog
indic
previou
ebolaviru
exposur
andor
infect
among
boend
hcw
higher
previous
report
serolog
survey
conduct
kikwit
ebov
outbreak
found
preval
among
health
worker
surround
villag
recent
studi
watsa
northeastern
region
drc
report
ebov
seropreval
local
efe
popul
explor
trend
patient
contact
highest
gp
seropreval
observ
unlik
contact
group
howev
within
categori
signific
heterogen
differ
may
explain
fact
outbreak
situat
everyon
includ
guard
administr
could
requir
assist
potenti
infect
person
regular
hospit
staff
abl
meet
demand
patient
potenti
lead
exposur
bodili
fluid
sick
patient
commun
member
group
also
like
reflect
gener
popul
may
indic
endem
ebov
exposur
area
howev
overal
result
like
suggest
gp
elisa
standalon
test
rel
nonspecif
may
due
unrel
nonspecif
bind
high
degre
glycosyl
ebov
gp
lend
nonspecif
recognit
altern
may
gp
sensit
viral
protein
presenc
crossreact
antibodi
direct
relat
virus
contrast
uniqu
mechan
ebolaviru
entri
lend
highli
specif
possibl
insensit
detect
prior
ebolaviru
infect
hcw
enrol
studi
demonstr
seroreact
multipl
ebov
protein
furthermor
identifi
hcw
never
report
infect
seroreact
least
serolog
test
may
also
abl
neutral
ebolaviru
expos
evd
includ
individu
seroreact
test
exhibit
neutral
capac
midwif
administr
volunt
known
whether
seroreact
assay
relat
ebov
exposur
particular
hcw
includ
analysi
particip
outbreak
respons
report
vari
level
contact
evd
patient
biolog
specimen
may
also
possibl
variat
antigen
respons
neutral
level
may
relat
asymptomat
minim
symptomat
infect
would
necessarili
detect
ill
due
ebov
possibl
seroreact
individu
could
also
expos
nonebov
filoviru
sever
limit
studi
unabl
interview
everi
hcw
everi
health
facil
health
zone
notabl
miss
hcw
lokolia
villag
outbreak
concentr
due
logist
constraint
impass
road
attempt
make
studi
popul
divers
possibl
enrol
particip
formal
inform
set
may
displac
normal
facil
support
outbreak
respons
may
misclassif
specif
hcw
occup
patient
contact
categor
base
occup
type
recal
contact
exposur
addit
hcw
may
play
multipl
differ
role
depend
need
facil
outbreak
respons
attempt
classifi
base
primari
posit
health
facil
furthermor
result
base
serolog
assay
adjust
cutoff
valu
affect
overal
result
thu
explor
rang
respons
figur
assay
use
higher
manufactur
cutoff
base
calibr
curv
provid
assum
higher
background
rate
crossreact
studi
highlight
elev
risk
hcw
drc
exposur
bloodborn
pathogen
gener
provid
adequ
train
hcw
infect
control
procedur
avail
person
protect
equip
reduc
exposur
bodili
fluid
patient
treat
evd
outbreak
occur
ultim
one
import
strategi
limit
spread
ebolaviru
bloodborn
pathogen
high
low
consequ
furthermor
find
rais
addit
question
ebov
exposur
risk
circul
viru
drc
current
serolog
gold
standard
ebolaviru
serolog
result
highlight
need
addit
research
better
understand
role
protein
play
immun
respons
better
understand
signific
evd
seroreact
risk
factor
associ
exposur
improv
abil
design
implement
local
sustain
strategi
limit
exposur
hcw
ebolaviru
pathogen
